INVESTABOT
Equity Research
XNAS · WHOLESALE-MISCELLANEOUS NONDURABLE GOODS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Natural Health Trends posted Q1 2026 revenue of $9.2M, down 14% from $10.7M a year ago, while EPS swung to a loss of $0.02 from a gain of $0.01 per diluted share in Q1 2025.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 1 accumulating - 4 trimming - 1 unchanged
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Renaissance Technologies | 581,415 | ~$1.8M | — | February 12, 2026 |
| Renaissance Technologies | 555,415 | ~$1.5M | -4.5% | May 14, 2026 |
| Renaissance Technologies | 544,077 | ~$1.0M | -2.0% | August 13, 2026 |
| BlackRock | 115,591 | ~$0.8M | — | August 13, 2024 |
| BlackRock | 115,339 | ~$0.4M | — | February 12, 2026 |
| Vanguard Group | 113,739 | ~$0.4M | — | January 29, 2026 |
| BlackRock | 116,134 | ~$0.3M | 0.7% | May 13, 2026 |
| Citadel Advisors | 60,871 | ~$0.2M | — | February 17, 2026 |
| BlackRock | 95,588 | ~$0.2M | -17.7% | August 7, 2026 |
| Citadel Advisors | 44,014 | ~$0.1M | -27.7% | May 15, 2026 |
| State Street | 27,012 | ~$83K | — | February 13, 2026 |
| State Street | 27,012 | ~$75K | 0.0% | May 15, 2026 |
| Citadel Advisors | 37,888 | ~$67K | -13.9% | August 14, 2026 |
| State Street | 27,012 | ~$48K | 0.0% | August 7, 2026 |
| Fidelity (FMR) | 158 | ~$0K | 100.0% | May 15, 2026 |
| Morgan Stanley | 17 | ~$0K | — | May 27, 2026 |
| Morgan Stanley | 18 | ~$0K | 5.9% | May 15, 2026 |
| Morgan Stanley | 26 | ~$0K | 44.4% | August 13, 2026 |
| Fidelity (FMR) | 0 | ~$0K | -100.0% | August 13, 2026 |